Atherosclerosis risk factor management - what's new for the neurologist?

Area of Science:

• Cardiovascular Medicine
• Public Health
• Neurology

Background:

• Stroke is a major global cause of mortality, with most cases linked to modifiable behavioral and metabolic risk factors.
• In Brazil, top cardiovascular mortality risks in 2019 included high blood pressure, poor diet, obesity, high LDL cholesterol, elevated blood glucose, and tobacco use.
• Effective management of risk factors is crucial for stroke prevention and patient outcomes.

Purpose of the Study:

• To review current evidence and recommendations for managing key risk factors in stroke patients.
• To focus on dyslipidemia, hypertension, and diabetes as critical targets for intervention.
• To provide a framework for healthcare professionals in addressing these prevalent risk factors post-stroke.

Main Methods:

• Literature review of scientific evidence.
• Analysis of recommendations from leading health organizations.
• Synthesis of data on the impact of dyslipidemia, hypertension, and diabetes on stroke recurrence and mortality.

Main Results:

• Dyslipidemia, hypertension, and diabetes are significant contributors to stroke risk and recurrence.
• Evidence supports statin therapy for dyslipidemia, antihypertensive medications for hypertension, and glycemic control for diabetes.
• Integrated management strategies are essential for comprehensive stroke risk reduction.

Conclusions:

• Aggressive management of dyslipidemia, hypertension, and diabetes is vital for secondary stroke prevention.
• Adherence to evidence-based treatment guidelines can significantly improve patient prognosis.
• Public health initiatives targeting these modifiable risk factors are necessary to reduce the global burden of stroke.